Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Superdonor FMT in Mild-to-moderate Ulcerative Colitis
NCT05739864Phase 2Recruiting
- Sponsor
- Policlinico Gemelli
- Start
- Feb 2023
- Primary completion
- Feb 2027
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic fecal microbiota in ulcerative colitis (UC), sponsored by Policlinico Gemelli. Started Feb 2023; status: recruiting.
02
Drugs
allogeneic fecal microbiota
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT05739864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05739864.